Saccharomyces boulardii and Lidoderm drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Saccharomyces boulardii (saccharomyces boulardii) and Lidoderm (lidocaine). Common drug interactions include nausea among females and acute hepatic failure among males.

The phase IV clinical study analyzes what interactions people have when they take Saccharomyces boulardii and Lidoderm. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Saccharomyces boulardii?

Saccharomyces boulardii has active ingredients of saccharomyces boulardii. eHealthMe is studying from 789 Saccharomyces boulardii users. Check the latest studies of Saccharomyces boulardii.

What is Lidoderm?

Lidoderm has active ingredients of lidocaine. It is often used in pain. eHealthMe is studying from 10,524 Lidoderm users. Check the latest studies of Lidoderm.

On Jul, 19, 2026

18 people who take Saccharomyces boulardii and Lidoderm together, and have interactions are studied.

Saccharomyces boulardii and Lidoderm drug interactions.

What are the common drug interactions of Saccharomyces Boulardii and Lidoderm, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Cellulitis (infection under the skin)
Colitis ulcerative (inflammation of colon with ulcer)
Constipation
Drug dependence
Hepatitis c
Hepatomegaly (abnormal enlargement of the liver)
Hypotension (abnormally low blood pressure)
Infection in an immunocompromised host
Platelet count decreased

male:

Acute hepatic failure
Anaemia (lack of blood)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Thrombocytopenia (decrease of platelets in blood)
Asthenia (weakness)
Cerebral small vessel ischaemic disease (inadequate blood supply to small blood vessel of brain)
Coma (state of unconsciousness lasting more than six hours)
Confusional state
Dehydration (dryness resulting from the removal of water)
Diarrhoea

What are the common drug interactions of Saccharomyces Boulardii and Lidoderm, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Cellulitis (infection under the skin)
Hepatitis c
Hypotension (abnormally low blood pressure)
Platelet count decreased
Skin ulcer
Drug abuse
Hepatitis b virus test positive
Thrombocytopenia (decrease of platelets in blood)
Hepatitis b
Substance abuse

40-49:

n/a

50-59:

n/a

60+:

Colitis ulcerative (inflammation of colon with ulcer)
Constipation
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Hepatic steatosis (fatty liver disease)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Thrombocytopenia (decrease of platelets in blood)
Acute hepatic failure
Anaemia (lack of blood)
Asthenia (weakness)
Cerebral small vessel ischaemic disease (inadequate blood supply to small blood vessel of brain)

What are the existing conditions these people have? *

Insomnia (sleeplessness): 12 people, 66.67%
Asthma: 7 people, 38.89%
Stress And Anxiety: 5 people, 27.78%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 5 people, 27.78%
Muscle Spasms (muscle contraction): 5 people, 27.78%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 27.78%
Migraine (headache): 5 people, 27.78%
Cellulitis (infection under the skin): 5 people, 27.78%
Depression: 2 people, 11.11%
Constipation: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Saccharomyces boulardii and Lidoderm?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously